BeStock  
Markets › Compare › EVO vs BCRX

EVO vs BCRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
EVO · Evotec$1.32 ▼ 8.97%
BCRX · BioCryst Pharmaceuticals$7.22 ▼ 1.37%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3670103136170Nov 24, '25May 26, '26Nov 20, '26
  • EVO -56.4%
  • BCRX +5.7%

Head to head

MetricEVOBCRX
Price$1.32$7.22
Change today▼ 8.97%▼ 1.37%
Market cap$469.11M$1.86B
Return, 3 months-30.2%-25.4%
Return, year to date-57.1%-7.4%
Return, 1 year-55.6%+3.6%
P/E (TTM)––
P/B0.7-4.7
P/E percentile vs own 5y77th70th
Dividend yield––
Revenue growth (YoY, latest qtr)+0.6%+13.1%
Net profit growth (YoY)+37.9%+193.9%
Gross margin10.3%97.9%
Operating margin-17.5%42.5%
Net margin-25.2%-37.4%
Return on equity-25.1%–
Analyst target vs. price+278.8%+135.5%
Analyst buy share100%67%
RSI (14)3235
30-day volatility72.7%40.4%
Max drawdown, 1 year-65.9%-35.0%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BCRX is the largest of the group by market value.
  • BCRX has returned the most over the past year.
  • BCRX is growing revenue fastest.
  • EVO keeps the most profit per dollar of sales.
  • BCRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top